Med 8 Admission Guidelines

 

The Med 8 service is responsible for the care of patients with active hematologic disorders who require active hematologic subspecialty input. In general terms, most, if not all, patients managed in the outpatient hematology clinic should be preferentially admitted to the Med 8 service. Patients cared by hematologists from outside institutions who present to Stanford hospital with active hematologic issues, should also preferentially be admitted to the Med 8 service.

In such, all patients with acute leukemia should be admitted to the Med 8 service or be followed by the Med 8 attending and fellow (in case of admission to the ICU and occasionally to surgical services). These patients undeniably require care from a hematology faculty member daily and therefore should always be admitted to the Med 8 service. Patients with other hematologic malignancies/MPNs who are admitted either for a likely complication of their disease or a likely complication from their disease therapy should generally be admitted to the Med 8 service. Patients admitted for complications of previously or newly diagnosed benign hematological conditions requiring active management (e.g. TTP, ITP, clotting disorders) should also be generally admitted to the Med 8 service.

 

Exceptions will sometimes need to be made to the above guidelines. Variables that are taken in consideration for these decisions include, total volume of the med 8/general medicine services in relation to their caps, complexity of the patients, number of expected admission from clinic and/or transfers from outside institutions, number of patients admitted to the ICU who are expected to transfer back to the Med 8 service, and number of housestaff available during that day. These are general guidelines; if there is disagreement as to which service the patient should be admitted to, this should be worked out based on an attending-to-attending discussion.